Outcomes/Comparative-Effectiveness Research

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Sunday, June 5 | 4:15 AM - 5:45 PM
Room 214A

Moderators are:
William C. Lavely, MD, Vanderbilt University in Nashville, Tenn.; and
Pradeep G. Bhambhvani, MD, University of Alabama at Birmingham.

Studies to be presented are:

  • Cost-effectiveness of FDG PET/CT in patients with Gram[+] bacteraemia;
  • Remnant ablation success and differentiated thyroid carcinoma outcome in stage III/IV patients: Recombinant human thyrotropin vs. thyroid hormone withdrawal;
  • The incidence of clinically important PET-negative CT-positive findings in a large clinical PET/CT practice;
  • Ga-68 DOTATOC PET/CT and In-111-DTPA-Octreotide SPECT for staging of enteropancreatic neuroendocrine tumors: Evaluation of costs and consequential costs;
  • Outpatient treatment of hyperthyroidism: How to protect the public?;
  • Direct comparison of neck pinhole dual-tracer and dual-phase sestamibi accuracies with and without SPECT/CT for parathyroid adenoma localization; and
  • Comparison of 2-deoxy-2-[F-18]fluoro-D-glucose uptake in the cerebellum and liver, reference organs for assessment of glucose metabolism, in oncologic patients.